Nephrotoxin Avoidance and Management

Introduction to Nephrotoxin Management

Discontinuing potentially nephrotoxic medications is recommended to avoid further kidney damage, as suggested by the Kidney International and Nature Reviews Nephrology guidelines 1, 2

Medication Management

Adjusting medication doses for patients with renal impairment is a crucial step in managing kidney health, although the specific details are not provided in this context 1, 2
Nephrotoxic medications that may be contributing to AKI should be discontinued, and medication doses should be adjusted for renal impairment 3, 4, 5

Fluid Management

The American College of Emergency Physicians and other societies recommend using balanced crystalloid solutions for fluid resuscitation in patients with hypochloremia in the setting of sepsis with liver and kidney dysfunction to correct chloride deficiency while avoiding hyperchloremic acidosis, as supported by the World Journal of Emergency Surgery 6
The KDIGO guidelines recommend crystalloids over colloids for fluid resuscitation in patients with acute kidney injury, with a strength of evidence rated as moderate to high 7
The European guideline on management of major bleeding recommends balanced crystalloids for fluid resuscitation, with a strength of evidence rated as high 8
Balanced crystalloids, such as lactated Ringer's solution, are recommended as the initial management for expansion of intravascular volume in patients with AKI, rather than 0.9% saline, to avoid hyperchloremic metabolic acidosis 3, 7, 9
The European Society of Intensive Care Medicine recommends considering intravenous albumin in addition to crystalloids for patients with spontaneous bacterial peritonitis, with a strength of evidence rated as moderate 10
Excessive fluid administration should be avoided, as it may worsen renal function through increased renal venous pressure, renal interstitial edema, and abdominal compartment syndrome 1, 11, 12
The World Journal of Emergency Surgery recommends avoiding excessive fluid administration leading to volume overload, with a strength of evidence rated as high 6
The KDIGO guidelines recommend avoiding 0.9% saline as primary fluid for resuscitation as it can worsen hyperchloremic acidosis, with a strength of evidence rated as moderate to high 6
The Society of Critical Care Medicine recommends avoiding hydroxyethyl starch solutions due to increased risk of kidney failure, with a strength of evidence rated as high 6

Patient-Specific Fluid Management

Trauma patients: Crystalloids are suggested for initial treatment of bleeding trauma patients (Grade 2C) 13, 14
Patients with sepsis or septic shock: Balanced crystalloids are probably recommended over 0.9% NaCl to reduce mortality and adverse renal events (Grade 2+ recommendation) 9
Patients with cerebrovascular disease: Avoid albumin and use balanced crystalloid solutions instead, with careful monitoring for signs of fluid overload and cerebral edema, as recommended by the British Journal of Anaesthesia and Kidney International guidelines 15, 16, 1
Patients with cardiovascular disease: Careful fluid management is recommended to avoid fluid overload complications, as stated by the Kidney International guidelines 1
Patients with cirrhosis and ascites: Intravenous albumin may be considered, as suggested by the Society of Critical Care Medicine and American College of Gastroenterology 17, 18

Monitoring and Assessment

Urine output, hemodynamic parameters, daily weights, intake/output balance, and repeated assessment of renal function should be monitored to adjust fluid administration 1, 13, 17, 18
The European Society of Intensive Care Medicine recommends monitoring serum electrolytes (including chloride) at least daily until normalized, with a strength of evidence rated as moderate 10
The KDIGO guidelines recommend monitoring acid-base status through arterial blood gases, with a strength of evidence rated as moderate to high 7
The Society of Critical Care Medicine recommends tracking changes in chloride levels (ΔCl) and monitoring for development of hepatorenal syndrome (HRS-AKI), with a strength of evidence rated as moderate 19
Target urine output should be >0.5 mL/kg/hr, with monitoring of vital signs, daily weights, and intake/output balance, as recommended by the National Institute of Diabetes and Digestive and Kidney Diseases 17, 18
Hourly diuresis (<0.5 ml/kg/h suggests kidney injury) and evaluation of response to fluids are essential in the management of acute pre-renal kidney injury 1
Patients with AKI should be evaluated for resolution, new onset, or worsening of pre-existing CKD at 3 months, and renal function should be checked as outpatients at least every 2-4 weeks during the first 6 months after discharge, as recommended by the National Kidney Foundation and Kidney Disease: Improving Global Outcomes (KDIGO) guidelines 18, 20, 15

Management of Acute Kidney Injury (AKI)

For stage 1 AKI, close monitoring, removal of risk factors, and plasma volume expansion in case of hypovolemia are recommended, with follow-up assessment every 2-4 days during hospitalization for patients who respond, as suggested by the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines and European Renal Association 17, 18
For stage 2-3 AKI, withdrawal of diuretics, volume expansion with albumin, and consideration of nephrology consultation and renal replacement therapy are recommended, with the International Club of Ascites algorithm followed for patients with cirrhosis, as recommended by the European Renal Association and European Association for the Study of the Liver 17, 18
Electrolytes, particularly potassium, should be monitored closely as renal function declines, and nephrology consultation should be considered for stage 2-3 AKI 3, 4